Literature DB >> 23180720

Capitalizing on diversity: an integrative approach towards the multiplicity of cellular mechanisms underlying myogenic responsiveness.

Darcy Lidington1, Rudolf Schubert, Steffen-Sebastian Bolz.   

Abstract

The intrinsic ability of resistance arteries to respond to transmural pressure is the single most important determinant of their function. Despite an ever-growing catalogue of signalling pathways that underlie the myogenic response, it remains an enigmatic mechanism. The myogenic response's mechanistic diversity has largely been attributed to 'hard-wired' differences across species and vascular beds; however, emerging evidence suggests that the mechanistic basis for the myogenic mechanism is, in fact, 'plastic'. This means that the myogenic response can change quantitatively (i.e. change in magnitude) and qualitatively (i.e. change in mechanistic basis) in response to environmental challenges (e.g. disease conditions). Consequently, understanding the dynamics of how the myogenic response capitalizes on its mechanistic diversity is key to unlocking clinically viable interventions. Using myogenic sphingosine-1-phosphate (S1P) signalling as an example, this review illustrates the remarkable plasticity of the myogenic response. We propose that currently unidentified 'organizational programmes' dictate the contribution of individual signalling pathways to the myogenic response and introduce the concept that certain signalling elements act as 'divergence points' (i.e. as the potential higher level regulatory sites). In the context of pressure-induced S1P signalling, the S1P-generating enzyme sphingosine kinase 1 serves as a divergence point, by orchestrating the calcium-dependent and -independent signalling pathways underlying microvascular myogenic responsiveness. By acting on divergence points, the proposed 'organizational programmes' could form the basis for the flexible recruitment and fine-tuning of separate signalling streams that underlie adaptive changes to the myogenic response and its distinctiveness across species and vascular beds.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180720     DOI: 10.1093/cvr/cvs345

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  10 in total

1.  Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel.

Authors:  Parker C Wilson; Wayne R Fitzgibbon; Sara M Garrett; Ayad A Jaffa; Louis M Luttrell; Michael W Brands; Hesham M El-Shewy
Journal:  Mol Endocrinol       Date:  2015-04-14

Review 2.  Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.

Authors:  Darcy Lidington; Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

Review 3.  Regulation of vascular tone and arterial blood pressure: role of chloride transport in vascular smooth muscle.

Authors:  Christian A Hübner; Björn C Schroeder; Heimo Ehmke
Journal:  Pflugers Arch       Date:  2015-01-16       Impact factor: 3.657

4.  Mechanical activation of angiotensin II type 1 receptors causes actin remodelling and myogenic responsiveness in skeletal muscle arterioles.

Authors:  Kwangseok Hong; Guiling Zhao; Zhongkui Hong; Zhe Sun; Yan Yang; Philip S Clifford; Michael J Davis; Gerald A Meininger; Michael A Hill
Journal:  J Physiol       Date:  2016-10-13       Impact factor: 5.182

5.  Mechanisms of sphingosine-1-phosphate-mediated vasoconstriction of rat afferent arterioles.

Authors:  Z Guan; F Wang; X Cui; E W Inscho
Journal:  Acta Physiol (Oxf)       Date:  2017-07-13       Impact factor: 6.311

6.  Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity.

Authors:  Firhan A Malik; Anja Meissner; Illya Semenkov; Steven Molinski; Stan Pasyk; Saumel Ahmadi; Hai H Bui; Christine E Bear; Darcy Lidington; Steffen-Sebastian Bolz
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

7.  Constitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressure.

Authors:  Jeffrey T Kroetsch; Andrew S Levy; Hangjun Zhang; Roozbeh Aschar-Sobbi; Darcy Lidington; Stefan Offermanns; Sergei A Nedospasov; Peter H Backx; Scott P Heximer; Steffen-Sebastian Bolz
Journal:  Nat Commun       Date:  2017-04-05       Impact factor: 14.919

8.  Experimental Subarachnoid Hemorrhage Drives Catecholamine-Dependent Cardiac and Peripheral Microvascular Dysfunction.

Authors:  Danny D Dinh; Darcy Lidington; Jeffrey T Kroetsch; Chloe Ng; Hangjun Zhang; Sergei A Nedospasov; Scott P Heximer; Steffen-Sebastian Bolz
Journal:  Front Physiol       Date:  2020-05-13       Impact factor: 4.566

9.  Circadian Rhythmicity in Cerebral Microvascular Tone Influences Subarachnoid Hemorrhage-Induced Injury.

Authors:  Darcy Lidington; Hoyee Wan; Danny D Dinh; Chloe Ng; Steffen-Sebastian Bolz
Journal:  Stroke       Date:  2021-12-15       Impact factor: 7.914

10.  Sphingosine-1-Phosphate Signaling Regulates Myogenic Responsiveness in Human Resistance Arteries.

Authors:  Sonya Hui; Andrew S Levy; Daniel L Slack; Marcus J Burnstein; Lee Errett; Daniel Bonneau; David Latter; Ori D Rotstein; Steffen-Sebastian Bolz; Darcy Lidington; Julia Voigtlaender-Bolz
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.